More than 130 suppliers
ISO certified
In-house tech support
we Connect you
Bio-Connect
ProductsBack/Influenza A virus PB2 protein antibody

Influenza A virus PB2 protein antibody

GTX125926
GeneTex
ApplicationsImmunoFluorescence, ImmunoPrecipitation, Western Blot, ImmunoCytoChemistry
Product group Antibodies
ReactivityVirus
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request
More than 130 suppliers
ISO certified
In-house tech support

Overview

  • Supplier
    GeneTex
  • Product Name
    Influenza A virus PB2 protein antibody
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1:1000-1:10000. ICC/IF: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    ImmunoFluorescence, ImmunoPrecipitation, Western Blot, ImmunoCytoChemistry
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    0.73 mg/ml
  • Conjugate
    Unconjugated
  • Host
    Rabbit
  • Isotype
    IgG
  • Reactivity
    Virus
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Sheppard CM, Goldhill DH, Swann OC, et al. An Influenza A virus can evolve to use human ANP32E through altering polymerase dimerization. Nat Commun. 2023,14(1):6135. doi: 10.1038/s41467-023-41308-4
    Read this paper
  • Sun L, Kong H, Yu M, et al. The SUMO-interacting motif in NS2 promotes adaptation of avian influenza virus to mammals. Sci Adv. 2023,9(28):eadg5175. doi: 10.1126/sciadv.adg5175
    Read this paper
  • Yang H, Dong Y, Bian Y, et al. The synergistic effect of residues 32T and 550L in the PA protein of H5 subtype avian influenza virus contributes to viral pathogenicity in mice. PLoS Pathog. 2023,19(7):e1011489. doi: 10.1371/journal.ppat.1011489
    Read this paper
  • Peacock TP, Sheppard CM, Lister MG, et al. Mammalian ANP32A and ANP32B Proteins Drive Differential Polymerase Adaptations in Avian Influenza Virus. J Virol. 2023,97(5):e0021323. doi: 10.1128/jvi.00213-23
    Read this paper
  • Günl F, Krischuns T, Schreiber JA, et al. The ubiquitination landscape of the influenza A virus polymerase. Nat Commun. 2023,14(1):787. doi: 10.1038/s41467-023-36389-0
    Read this paper
  • Swann OC, Rasmussen AB, Peacock TP, et al. Avian Influenza A Virus Polymerase Can Utilize Human ANP32 Proteins To Support cRNA but Not vRNA Synthesis. mBio. 2023,14(1):e0339922. doi: 10.1128/mbio.03399-22
    Read this paper
  • Panagiotidis GD, Müller C, Binder M, et al. Influenza A virus strain PR/8/34, but neither HAM/2009 nor WSN/33, is transiently inhibited by the PB2-targeting drug paliperidone. Arch Virol. 2023,168(2):63. doi: 10.1007/s00705-022-05696-0
    Read this paper
  • Huang Y, Li Y, Chen Z, et al. Nisoldipine Inhibits Influenza A Virus Infection by Interfering with Virus Internalization Process. Viruses. 2022,14(12). doi: 10.3390/v14122738
    Read this paper
  • Chen J, Liu J, Chen Z, et al. Nonmuscle myosin IIA promotes the internalization of influenza A virus and regulates viral polymerase activity through interacting with nucleoprotein in human pulmonary cells. Virol Sin. 2023,38(1):128-141. doi: 10.1016/j.virs.2022.12.002
    Read this paper
  • Yang H, Dong Y, Bian Y, et al. The influenza virus PB2 protein evades antiviral innate immunity by inhibiting JAK1/STAT signalling. Nat Commun. 2022,13(1):6288. doi: 10.1038/s41467-022-33909-2
    Read this paper

Datasheet

Download Datasheet

FAQ

Go to our frequently asked questions